兔抗EFEMP2多克隆抗體

Background:

A large number of extracellular matrix proteins have been found to contain variations of the epidermal growth factor (EGF) domain and have been implicated in functions as diverse as blood coagulation, activation of complement and determination of cell fate during development. The protein encoded by this gene contains four EGF2 domains and six calcium-binding EGF2 domains. This gene is necessary for elastic fiber formation and connective tissue development. Defects in this gene are cause of an autosomal recessive cutis laxa syndrome.

Applications:

WB, IHC, IF

Name of antibody:

EFEMP2

Immunogen:

Synthesized peptide derived from internal of human EFEMP2.

Full name:

EGF containing fibulin-like extracellular matrix protein 2

Synonyms：

MBP1; UPH1; FBLN4; ARCL1B

SwissProt:

O95967

IHC positive control:

Human placenta tissue

IHC Recommend dilution:

50-100

WB Predicted band size:

49 kDa

WB Positive control:

K562 cells and NIH/3T3 cells lysates

WB Recommended dilution:

500-3000

IF positive control:

A549 cells

IF Recommend dilution:

100-500